Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Improved control of SARS-CoV-2 by treatment with a nucleocapsid-specific monoclonal antibody.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Improved control of SARS-CoV-2 by treatment with a nucleocapsid-specific monoclonal antibody.
Improved control of SARS-CoV-2 by treatment with a nucleocapsid-specific monoclonal antibody. J Clin Invest. 2022 12 01; 132(23).
View in:
PubMed
subject areas
Animals
Antibodies, Monoclonal
Antibodies, Viral
Mice
Nucleocapsid
Spike Glycoprotein, Coronavirus
authors with profiles
Igor J. Koralnik